文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence
侵权投诉

Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence

DNA damage, Mitomycin, cell senescence

Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence

Figure 2. Cell cycle changes following prolonged treatment with low concentrations of MMC. (A) DNA content frequency histograms of the untreated and treated cells. the cell cycle phases of cells at diploid and higher DNA ploidy level are marked (see the text). (B) the percentage of cells in respective phases of the cell cycle and at different DNA ploidy is shown on the bar graphs.

were positive for EdU (Fig. 7B). It was evident that even though the majority of the cells appeared to be senescent, there were still a few cells that continued to traverse S phase.

To determine whether the cells that incorporated EdU were capable of continued proliferation, the cells from these cultures were subjected to a clonogenicity assay. To this end, the cells treated for 6 d with 0.01 or 0.02 μg/ml MMC were trypsinized and re-plated at low cell densities. There was no evidence that senescence affected the ability of cells to reattach following tryp-sinization (Fig. 8A). Control slides were also plated at a low cell density and all cells were allowed to grow for 1 week to determine their ability to form colonies. While untreated cells produced on average 398 colonies (from 1,000 cells) (Fig. 8B), demonstrat-ing the normal cloning efficiency of A549 cells to be approxi-mately 40%; the cells treated with 0.01 μg/ml MMC had only 1.8% clonogenicity, whereas, in repeated experiments, there was not a single colony formed on slides from the cells treated with 0.02 μg/ml MMC (Fig. 8A). It should be noted that cells treated with MMC in the clonogenicity experiment showed a similar decrease in mp/area ratio and EdU incorporation as was previ-ously observed following 6 d treatment (Fig. S3).

Discussion

The present data indicate that treatment of A549 cells with rela-tively high (0.1 – 2.0 μg/ml) concentrations of MMC resulted in nearly total suppression of DNA replication that manifested as a distinct arrest in S phase with little or no change in the cell cycle distribution; apoptosis was induced at longer culture times following treatment with 2.0 μg/ml MMC (Fig. 1). Prolonged (6 d) exposure of cells to 0.01 or 0.02 μg/ml MMC, however, led to induction of cell senescence. In fact, the irreversible senes-cence, manifested as the total cell’s inability to form colonies, was observed after treatment with 0.02 μg/ml MMC, while few cells were still able to proliferate after exposure to 0.01 μg/ml (Fig. 8). This correlated with the “depth” of senescence assessed by mor-phometric analysis of the cell’s nuclear size and shape (mp/area) after 6 d of treatment, as the SI index25 decreased from 1.0 in control cells to 0.41 vs. 0.34 in cells exposed to 0.01 and 0.02 μg/ml MMC, respectively (Fig. 6B). These MMC concentrations, which are two orders of magnitude lower than the MTD used in cytotoxic chemotherapy regimens, make our findings clini-cally relevant. Thus, the prolonged exposure of cells to a DNA damaging drug at concentrations sufficient to induce persistent replication stress (reflected by histone H2AX phosphorylation and induction of p21WAF1) but low enough not to suppress protein synthesis (reflected by increase in cell size) can result in induction of reproductive cell death.

There is significant evidence that induction of cell senescence may be achieved by variety of anticancer drugs. An in vitro study using high cytotoxic doses of DNA topoisomerase inhibitors revealed that, in response to treatment, two of five cancer cell lines underwent apoptosis, while the other three tended to be permanently arrested in the cell cycle or senescent.26 An in vivo study in mice with myc-induced lymphomas found the presence of senescent cells following treatment with a single high dose of cyclophosphamide and the presence of senescent cells correlated with better survival.27 In an important and perhaps underappre-ciated observation, senescent cells were also seen in over 40% of biopsies from patients with lung or breast cancer that had been treated with traditional cytotoxic chemotherapy.26,28 It is evident from these studies that even following treatment with high drug concentrations designed to kill cells by apoptosis, some cells respond by undergoing senescence. However, no thorough stud-ies examining senescence of cancer cells following the clinical use of continuous exposure to low or moderate levels of DNA damag-ing agents have been carried out.

As mentioned, metronomic chemotherapy involves continu-ous or frequent treatment with low doses, typically 1/3–1/2 of the MTD, of anticancer drugs.14 The beneficial effects of this

doc.guandang.net Cell Cycle 3135

上一页第4页

TOP相关主题

你可能喜欢

热门文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email